PT3390412T - Derivados solúveis em água de compostos de 3,5-difenil-diazole - Google Patents
Derivados solúveis em água de compostos de 3,5-difenil-diazoleInfo
- Publication number
- PT3390412T PT3390412T PT168094258T PT16809425T PT3390412T PT 3390412 T PT3390412 T PT 3390412T PT 168094258 T PT168094258 T PT 168094258T PT 16809425 T PT16809425 T PT 16809425T PT 3390412 T PT3390412 T PT 3390412T
- Authority
- PT
- Portugal
- Prior art keywords
- diphenyl
- water
- soluble derivatives
- diazole compounds
- diazole
- Prior art date
Links
- JXHKUYQCEJILEI-UHFFFAOYSA-N 3,5-diphenyl-1h-pyrazole Chemical class C=1C(C=2C=CC=CC=2)=NNC=1C1=CC=CC=C1 JXHKUYQCEJILEI-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/4155—1,2-Diazoles non condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
- C07F9/11—Esters of phosphoric acids with hydroxyalkyl compounds without further substituents on alkyl
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
- C07F9/65515—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring
- C07F9/65517—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring condensed with carbocyclic rings or carbocyclic ring systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15199972 | 2015-12-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT3390412T true PT3390412T (pt) | 2021-06-22 |
Family
ID=54850017
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT168094258T PT3390412T (pt) | 2015-12-14 | 2016-12-14 | Derivados solúveis em água de compostos de 3,5-difenil-diazole |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US10308671B2 (pt) |
| EP (1) | EP3390412B1 (pt) |
| JP (1) | JP6898931B2 (pt) |
| KR (1) | KR102671166B1 (pt) |
| CN (1) | CN108473516B (pt) |
| AU (1) | AU2016372408B2 (pt) |
| BR (1) | BR112018011994B1 (pt) |
| CA (1) | CA3008334C (pt) |
| CL (1) | CL2018001570A1 (pt) |
| DK (1) | DK3390412T3 (pt) |
| ES (1) | ES2873510T3 (pt) |
| HU (1) | HUE054815T2 (pt) |
| IL (1) | IL260011B (pt) |
| MX (1) | MX2018006877A (pt) |
| NZ (1) | NZ742979A (pt) |
| PH (1) | PH12018501276A1 (pt) |
| PL (1) | PL3390412T3 (pt) |
| PT (1) | PT3390412T (pt) |
| RU (1) | RU2764131C2 (pt) |
| WO (1) | WO2017102893A1 (pt) |
| ZA (1) | ZA201803865B (pt) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH713150A2 (fr) * | 2016-11-23 | 2018-05-31 | Eta Sa Mft Horlogere Suisse | Mécanisme régulateur à résonateur rotatif à guidage flexible entretenu par un échappement libre à ancre. |
| US10368502B2 (en) | 2017-09-25 | 2019-08-06 | Multiple Energy Technologies Llc | Bioceramic and carbon-based hydroponic systems, methods and devices |
| CN114728927A (zh) | 2019-11-19 | 2022-07-08 | 莫达戈有限公司 | 用于诊断、治疗和预防与α-突触核蛋白的聚集相关的疾病的新颖化合物 |
| AU2023227368A1 (en) * | 2022-03-01 | 2024-07-18 | Modag Gmbh | Pharmaceutical composition comprising diphenyldiazole derivatives and methods of use |
| CN115337301A (zh) * | 2022-07-22 | 2022-11-15 | 汕头大学医学院第一附属医院 | Anle138b在制备改善饮食诱导胰岛素抵抗药物中的应用 |
| CN116399983B (zh) * | 2023-06-09 | 2023-08-15 | 天津辰欣药物研究有限公司 | 一种利用gc-ms法检测二叔丁基氯甲基磷酸酯残留量的方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7745625B2 (en) * | 2004-03-15 | 2010-06-29 | Bristol-Myers Squibb Company | Prodrugs of piperazine and substituted piperidine antiviral agents |
| NZ564326A (en) * | 2005-06-16 | 2010-01-29 | Cv Therapeutics Inc | Prodrugs of A2B adenosine receptor antagonists |
| JP5627453B2 (ja) * | 2008-03-31 | 2014-11-19 | 株式会社レナサイエンス | プラスミノーゲンアクチベーターインヒビター−１阻害剤 |
| HUE053352T2 (hu) * | 2008-06-09 | 2021-06-28 | Univ Muenchen Ludwig Maximilians | Új hatóanyagok fehérje-aggregációval kapcsolatos betegségeknél és/vagy neurodegeneratív betegségeknél szerepet játszó fehérjék aggregációjának gátlására |
| EP2585455B1 (en) * | 2010-06-24 | 2019-08-07 | The Regents of the University of California | Compounds and uses thereof in modulating levels of various amyloid beta peptide alloforms |
| LT2864292T (lt) * | 2012-06-08 | 2017-07-10 | Theravance Biopharma R&D Ip, Llc | Neprilizino inhibitoriai |
-
2016
- 2016-12-14 JP JP2018532323A patent/JP6898931B2/ja active Active
- 2016-12-14 PT PT168094258T patent/PT3390412T/pt unknown
- 2016-12-14 CA CA3008334A patent/CA3008334C/en active Active
- 2016-12-14 WO PCT/EP2016/081084 patent/WO2017102893A1/en active Application Filing
- 2016-12-14 PL PL16809425T patent/PL3390412T3/pl unknown
- 2016-12-14 RU RU2018125590A patent/RU2764131C2/ru active
- 2016-12-14 MX MX2018006877A patent/MX2018006877A/es unknown
- 2016-12-14 BR BR112018011994-6A patent/BR112018011994B1/pt active IP Right Grant
- 2016-12-14 KR KR1020187020192A patent/KR102671166B1/ko active IP Right Grant
- 2016-12-14 ES ES16809425T patent/ES2873510T3/es active Active
- 2016-12-14 DK DK16809425.8T patent/DK3390412T3/da active
- 2016-12-14 NZ NZ742979A patent/NZ742979A/en unknown
- 2016-12-14 EP EP16809425.8A patent/EP3390412B1/en active Active
- 2016-12-14 US US16/062,258 patent/US10308671B2/en active Active
- 2016-12-14 AU AU2016372408A patent/AU2016372408B2/en active Active
- 2016-12-14 HU HUE16809425A patent/HUE054815T2/hu unknown
- 2016-12-14 CN CN201680073089.1A patent/CN108473516B/zh active Active
-
2018
- 2018-06-11 ZA ZA2018/03865A patent/ZA201803865B/en unknown
- 2018-06-13 CL CL2018001570A patent/CL2018001570A1/es unknown
- 2018-06-13 IL IL260011A patent/IL260011B/en unknown
- 2018-06-14 PH PH12018501276A patent/PH12018501276A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN108473516A (zh) | 2018-08-31 |
| US20180370997A1 (en) | 2018-12-27 |
| IL260011A (en) | 2018-07-31 |
| CL2018001570A1 (es) | 2018-12-28 |
| JP6898931B2 (ja) | 2021-07-07 |
| AU2016372408B2 (en) | 2021-05-13 |
| JP2019501167A (ja) | 2019-01-17 |
| IL260011B (en) | 2021-12-01 |
| CA3008334C (en) | 2024-01-02 |
| WO2017102893A1 (en) | 2017-06-22 |
| BR112018011994B1 (pt) | 2022-07-19 |
| MX2018006877A (es) | 2018-09-18 |
| EP3390412A1 (en) | 2018-10-24 |
| KR102671166B1 (ko) | 2024-05-31 |
| CA3008334A1 (en) | 2017-06-22 |
| RU2764131C2 (ru) | 2022-01-13 |
| NZ742979A (en) | 2022-05-27 |
| PH12018501276A1 (en) | 2019-01-28 |
| US10308671B2 (en) | 2019-06-04 |
| RU2018125590A (ru) | 2020-01-20 |
| KR20180089511A (ko) | 2018-08-08 |
| PL3390412T3 (pl) | 2021-10-25 |
| ES2873510T3 (es) | 2021-11-03 |
| DK3390412T3 (da) | 2021-06-21 |
| ZA201803865B (en) | 2019-04-24 |
| RU2018125590A3 (pt) | 2020-04-21 |
| CN108473516B (zh) | 2021-06-18 |
| EP3390412B1 (en) | 2021-04-14 |
| AU2016372408A1 (en) | 2018-06-21 |
| HUE054815T2 (hu) | 2021-10-28 |
| BR112018011994A2 (pt) | 2018-12-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL264092A (en) | 1, 3-dihydroxy-phenyl derivatives are useful as immunomodulators | |
| HK1255045A1 (zh) | 取代的氧代吡啶衍生物 | |
| IL254870A0 (en) | Quinoxaline histories are transmuted | |
| IL253381B (en) | History of h9–pyrrolo–dipyridine | |
| IL271607A (en) | New azaquinoline histories | |
| HRP20200133T1 (hr) | Novi supstituirani derivati cijanoindolina kao inhibitori nik | |
| IL260011B (en) | History of water-soluble 5,3-diphenyldiazole compounds | |
| HK1245258A1 (zh) | 新的二氟酮酰胺衍生物 | |
| IL271290A (en) | Dihydro-pyrrolo-pyridine derivatives | |
| HUE058182T2 (hu) | Grizeofulvin vegyület | |
| HK1256825A1 (zh) | 取代的5，6-二氫-6-苯基苯並[f]異喹啉-2-胺化合物的固體形式 | |
| IL251005B (en) | Pyrido-oxazinone derivatives | |
| SG11201803584RA (en) | 1,4-dicarbonyl-piperidyl derivatives | |
| HK1254800A1 (zh) | 2，3，4，5-四氫吡啶-6-胺衍生物 | |
| HK1252767A1 (zh) | 作為eaat3抑制劑的吡唑-吡啶衍生物 | |
| PT3319956T (pt) | Derivados de oxopiridina substituída | |
| TWI562978B (en) | Method for preparation of 1,4-cyclohexanedialkanol | |
| HUP1500451A2 (en) | Processes for the preparation of 1,4,7-triaza-cyclononane derivatives and intermediates |